Comparison
2p13 2 Microdeletion Syndrome C4749460 vs 16p12 2 Microdeletion Syndrome C4708497
Clinical comparison between 2p13 2 Microdeletion Syndrome and 16p12 2 Microdeletion Syndrome for differential diagnosis and treatment planning.
2p13 2 Microdeletion Syndrome C4749460
A rare chromosomal condition where a small segment is missing from chromosome 2. Features vary based on which genes are affected. Care focuses on addressing specific symptoms.
16p12 2 Microdeletion Syndrome C4708497
A rare genetic condition where a small piece of chromosome 16 is missing. It can cause developmental delays, intellectual disability, and recurrent infections in some individuals. Treatment involves supportive therapies and medical management of symptoms.
6 comparison axes
Onset
2p13 2 Microdeletion Syndrome C4749460
0-0
16p12 2 Microdeletion Syndrome C4708497
0-5
Onset patterns differ
Severity
2p13 2 Microdeletion Syndrome C4749460
severe
16p12 2 Microdeletion Syndrome C4708497
moderate
Different severity levels
Chronic
2p13 2 Microdeletion Syndrome C4749460
Chronic
16p12 2 Microdeletion Syndrome C4708497
Chronic
Differing course
Communicable
2p13 2 Microdeletion Syndrome C4749460
No
16p12 2 Microdeletion Syndrome C4708497
No
Different transmission
Body System
2p13 2 Microdeletion Syndrome C4749460
congenital
16p12 2 Microdeletion Syndrome C4708497
congenital
Same/different system
Category
2p13 2 Microdeletion Syndrome C4749460
rare-disease
16p12 2 Microdeletion Syndrome C4708497
genetic
Different category
Bottom line
2p13-2-microdeletion-syndrome-C4749460 and 16p12-2-microdeletion-syndrome-C4708497 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 2p13 2 Microdeletion Syndrome C4749460 | 16p12 2 Microdeletion Syndrome C4708497 | Discriminating power |
|---|---|---|---|
| Chromosomal region | A small segment is missing at 2p13.2; affected genes and features vary. | A small segment is missing at 16p12.2; reported features vary among individuals. | High |
| Development or learning | A specific developmental pattern is not established in the supplied description. | Developmental delay and intellectual disability are described in some individuals. | Moderate |
| Recurrent infections | Recurrent infection is not established from the supplied source. | Recurrent infections are reported in some, but not necessarily all, individuals. | Moderate |
When to favor each condition
Choose 2p13 2 Microdeletion Syndrome C4749460 when
Testing identifies a deletion at 2p13.2
The named chromosomal locus supports this condition more than symptoms alone.
High
Findings are recognized at birth
The supplied onset is congenital, although the feature pattern remains variable.
Moderate
Planning care for a labeled severe condition
Severity is recorded as severe, but individual needs require clinician assessment.
Low
Choose 16p12 2 Microdeletion Syndrome C4708497 when
Testing identifies a deletion at 16p12.2
The chromosome 16 locus distinguishes it from a chromosome 2 deletion.
High
Early developmental delay or intellectual disability
These features are described in some people with this deletion.
Moderate
Recurrent infections plus a compatible genetic result
Infections are reported in some individuals and warrant medical evaluation.
Moderate
How key tests differ
| Test | 2p13 2 Microdeletion Syndrome C4749460 | 16p12 2 Microdeletion Syndrome C4708497 | Interpretation |
|---|---|---|---|
| Chromosomal microarray | May show copy-number loss involving 2p13.2. | May show copy-number loss involving 16p12.2. | Genomic location distinguishes the findings; a clinician should confirm the result. |
| Karyotype | A small 2p13.2 deletion may not be visible. | A small 16p12.2 deletion may not be visible. | A normal karyotype does not exclude either microdeletion. |
| Symptom-directed tests | No single expected laboratory abnormality is established. | Infection evaluation may be considered when infections recur; no cutoff is established. | An abnormal test is not itself a diagnosis and needs clinical correlation. |
Prognosis comparison
2p13 2 Microdeletion Syndrome C4749460
- Outcome
- Long-term outcome is not established; the supplied course is chronic and severity severe.
- Factors
- Affected genes, congenital findings, and available supports influence needs.
16p12 2 Microdeletion Syndrome C4708497
- Outcome
- Outcome varies; supplied severity is moderate, with possible developmental or infection-related needs.
- Factors
- Degree of delay, infection frequency, and supportive care may influence course.
Time frame: Needs may continue lifelong and change from infancy through adulthood.
Individual genetic findings, associated medical issues, and coordinated care are important.
Complications comparison
| Complication | Presentation |
|---|---|
| Developmental needs | Variable; a specific pattern is not established. Delay or intellectual disability may occur in some people. Developmental assessment is reasonable for either condition. |
| Associated medical problems | Depend on affected genes and are not specified here. Recurrent infections may occur in some individuals. Neither problem should be assumed to affect every person. |
| Family recurrence | Inheritance is not established from the supplied data. Inheritance is not established from the supplied data. Genetic counseling can discuss uncertainty without assuming a mechanism. |
Patient education highlights
- HighMeaning of the result
A microdeletion means a small chromosome segment is missing and is confirmed by genetic testing.
- HighVariable presentation
People with the same named deletion can differ; one result does not predict every outcome.
- MediumCare approach
Described care is supportive and symptom-focused. No treatment dose or cure is established here.